Martine Rothblatt Net Worth & Insider Trades
Martine Rothblatt - CHAIRPERSON & CEO, United Therapeutics Corp
What is Martine Rothblatt's Net Worth?
The current estimated net worth of United Therapeutics Corp's CHAIRPERSON & CEO, Martine Rothblatt, is estimated to be about $732.99M . Martine Rothblatt owns about 644,313 units of United Therapeutics Corp common stock. In the last 20 years at United Therapeutics Corp, Martine Rothblatt has sold an estimated value of $738.98M worth.
What is Martine Rothblatt's Past Insider Trading?
Martine Rothblatt's largest purchase order was 39,014 units , worth over $3.32M on June 11, 2009. Martine Rothblatt's largest sale order was 50,000 units , worth over $6.23M on September 16, 2014. In total, Martine Rothblatt has made about 851 transactions over 20 years of their time at United Therapeutics Corp. Martine Rothblatt usually trades in December, with the busiest year in 2015. The most recent transaction was a sale order of 8,000 units , worth over $1.83M on May 3, 2023.
MARTINE ROTHBLATT
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What are United Therapeutics Corp's Past Insider Trades?
United Therapeutics Corp's most recent insider trade came on June 1, 2023 by Paul Mahon who sold 6,000 units worth $1.25M . In the last 20 years, insiders at United Therapeutics Corp have sold an estimated value of $1.62B and bought an estimated value of $613.26M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Martine Rothblatt, CHAIRPERSON & CEO, Paul Mahon, EVP & GENERAL COUNSEL, and Roger Jeffs .
UNITED THERAPEUTICS Corp Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||